Black health matters: Distribute COVID-19 vaccine equitably - 0 views
-
Moderna’s RNA vaccine candidate is joining the ranks of Pfizer/BioN Tech’s already-announced RNA vaccine candidate with preliminary Phase 3 clinical trials results showing excellent efficacy. Pfizer’s preliminary results now show 95% efficacy and Moderna’s show 94% efficacy. The FDA's bar of 50% efficacy could potentially be cleared with Olympian results if the final reviews by the FDA judges are in agreement with the preliminary results.
-
Following the FDA rules, COVID-19 vaccine candidates must have been observed in volunteer trial participants for at least 2 months and will be continued to be observed in Phase 4 for at least 2 years after the vaccine is made available.
-
Emergency Use Authorization (EUA) was added to FDA authority by the Pandemic and All-Hazards Preparedness Reauthorization Act of 2013, which authorizes the FDA to facilitate availability of an unapproved product during a state of emergency such as this public health COVID-19 pandemic.
- ...6 more annotations...
-
COVID-19 translational research is moving science from the bench preclinical stage of cell and animal research and rapidly through three phases of clinical trials. We can anticipate vaccines being at the patient/population “bedside” in the next few months.
-
Delaware has created a framework for COVID-19 vaccine distribution when it becomes available which can be found on coronavirus.Delaware.gov. Delaware’s distribution will have three phases
-
The state will begin with healthcare workers and those caring for vulnerable populations and other first responders and critical infrastructure workers. The second phase will vaccinate vulnerable persons: people over 65, those with chronic health conditions, homelessness and other vulnerabilities.Lastly, the rest of our Delaware population of more than 970,000 will be vaccinated.
-
And sadly, Black and Brown communities have been disproportionately infected and affected by COVID-19 here in Delaware and throughout the U.S. These communities remain vulnerable.
-
When COVID-19 vaccines become available, Black and Brown communities must be given equitable access to the vaccine.
-
The disproportionate effects of the COVID-19 pandemic on Black and Brown communities has pulled back a curtain of silence on the systemic racism in the health and healthcare systems in Delaware and across the United States.